Core Insights - The China Securities Regulatory Commission (CSRC) has released a report on the status of domestic companies' overseas securities issuance and listing applications as of November 21, 2025, indicating ongoing activity in the Hong Kong IPO market [1] Group 1: Companies Seeking IPOs - Dermavon Holdings Limited (德镁医药有限公司) is in the process of indirect overseas listing with materials submitted to the Hong Kong Stock Exchange [3] - Haote Energy Conservation Technology Co., Ltd. (豪特节能) and Zhejiang Shimai Pharmaceutical Co., Ltd. (时迈药业) are both pursuing direct overseas listings on the Hong Kong Stock Exchange [3] - Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (迈瑞生物) is also seeking a direct overseas listing, with multiple financial institutions involved in the underwriting process [3] - Chengdu Canopus Robotics Technology Co., Ltd. (卡诺普机器人) and Beijing Defeng New Journey Technology Co., Ltd. (德风科技) are similarly applying for direct listings on the Hong Kong Stock Exchange [3] Group 2: Companies with Full Circulation Applications - Companies such as Youbao Online Technology Co., Ltd. (友宝在线), Yaojie Ankang (药捷安康), and Bama Tea Co., Ltd. (八马茶业) have submitted applications for full circulation of their shares, indicating a shift towards increased liquidity in the market [3] - Other companies like Shanghai Yingtai Medical Devices Co., Ltd. (瑛泰医疗) and Lianlian Digital Technology Co., Ltd. (连连数字) are also part of this trend, with applications received by the CSRC [3]